PUBLISHER: QYResearch | PRODUCT CODE: 1091509
PUBLISHER: QYResearch | PRODUCT CODE: 1091509
Due to the COVID-19 pandemic, the global Activated Polyethylene Glycol (PEG) market size is estimated to be worth US$ 230.00 million in 2022 and is forecast to a readjusted size of US$ 937.14 million by 2028 with a CAGR of 26.38% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Linear PEGs accounting for 58.00% of the Activated Polyethylene Glycol (PEG) global market in 2021, is projected to value US$ 537.71 million by 2028, growing at a revised 26.16% CAGR from 2022 to 2028. While Pharmaceutical Industry segment is altered to an 26.95% CAGR throughout this forecast period.
The global key manufacturers of Activated Polyethylene Glycol (PEG) include NOF, JenKem Technology, Nektar Therapeutics, Dr. Reddy's Laboratories, Merck, Chemgen Pharma, SINOPEG, SunBio, and Laysan Bio, etc. In 2021, the global top five players hold a share approximately 76.93% in terms of revenue.
In terms of production side, this report researches the Activated Polyethylene Glycol (PEG) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Activated Polyethylene Glycol (PEG) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Activated Polyethylene Glycol (PEG) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Activated Polyethylene Glycol (PEG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type, and by Application for the period 2017-2028.